Related Experiment Video
Updated: May 3, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Prediction of IL4 inducing peptides
Sandeep Kumar Dhanda1, Sudheer Gupta1, Pooja Vir1
1Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh 160036, India.
Predicting Interleukin-4 (IL4) inducing peptides is now possible. New models identify specific residue patterns and motifs, aiding in the design of peptides for desired T-helper 2 responses.
Area of Science:
- Immunology
- Computational Biology
Background:
- Interleukin-4 (IL4) is a key cytokine in T-helper 2 (Th2) immune responses.
- IL4, secreted by CD4+ T cells, directs antibody class switching, hematopoiesis, inflammation, and T-cell effector functions.
- Understanding IL4 induction mechanisms is crucial for developing targeted immunotherapies.
Purpose of the Study:
- To investigate the predictability of Interleukin-4 (IL4) inducing peptides.
- To identify sequence characteristics differentiating IL4-inducing from non-inducing peptides.
Main Methods:
- Analysis of a dataset containing 904 experimentally validated IL4-inducing and 742 non-inducing MHC class II binders.
- Development of classification models utilizing amino acid composition, pairs, and motif information.
Main Results:
- Identification of preferred residue types at specific positions within IL4-inducing peptides.
- Observed differences in compositional and motif patterns between IL4-inducing and non-inducing epitopes.
- A hybrid classification model combining amino acid pairs and motif information achieved 75.76% accuracy and an MCC of 0.51.
Conclusions:
- It is feasible to predict IL4-inducing peptides with reasonable accuracy.
- Developed predictive models can assist in designing peptides to elicit specific Th2 immune responses.
- This approach holds potential for advancing immunomodulatory drug design.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024